The following points summarize information from a Joint Statement of the
Perinatal Quality Foundation, ACMG, ACOG, the Society for Maternal-Fetal Medicine (SMFM), and the National Society of Genetic Counselors on “points to consider” when performing expanded carrier screening in reproductive medicine.
During the pandemic, physician self-care and organizational efforts to protect physician wellbeing are vital to maintaining a healthy and able workforce, which in turn enables a strong response to the ongoing health crisis.
Considerable heterogeneity exists in reported outcomes and measures used in clinical trials of treatments for genitourinary syndrome of menopause (GSM), which impacts between 40% and 60% of postmenopausal women, according to a systematic review in the journal Menopause.
A prospective study of generally healthy perimenopausal women has concluded that low bone mineral density (BMD) is significantly linked with periodontal disease in women over 58 years old, and independent of tobacco consumption or oral hygiene.